Patanjali Foods Limited has issued a disclosure regarding action initiated by the Food and Drug Administration (FDA), Maharashtra, concerning a batch of its Patanjali Cow Ghee held by a super distributor. The communication was not directly addressed to the company, and no authenticated laboratory report has yet confirmed substandard quality or adulteration. The company is monitoring the situation and will provide further updates as required.
FDA Action on Cow Ghee Stock
Patanjali Foods Limited has formally informed stakeholders about an action initiated by the Food and Drug Administration (FDA) in Maharashtra. The action pertains to a specific stock of Patanjali Cow Ghee held by one of the company’s super distributors or Food Business Operators (FBO) in Maharashtra. The company received this information from the concerned FBO and has obtained a copy of the communication for its review.
No Confirmed Quality Failure Yet
According to the information available to Patanjali Foods, FDA officials collected samples of the identified Cow Ghee batches for laboratory testing. However, as of the disclosure date, neither the company nor the FBO has received any authenticated laboratory test report that confirms the samples have failed to meet the prescribed quality parameters. The company emphasizes that the mere collection of samples for testing does not, by itself, establish adulteration or substandard quality.
Restrictions Placed on Stock
The communication received by the FBO indicates that directions have been issued concerning the identified stock, including a restriction on its sale pending further action. Patanjali Foods asserts that the sampling and the subsequent directions regarding the stock do not, in themselves, contain any confirmed laboratory finding of adulteration or failure to meet quality standards.
Commitment to Quality and Compliance
Patanjali Foods reiterates its unwavering commitment to maintaining the highest standards of product quality, consumer safety, and regulatory compliance. The company is actively seeking all relevant details and supporting documents from the concerned FBO and regulatory authorities. It pledges full cooperation with the authorities and will facilitate independent verification of the concerned batches as needed. The company will examine any authenticated laboratory reports that establish deviations from quality standards and will take appropriate corrective actions in compliance with applicable laws and regulations.
Company’s Current Stance
The company believes that any conclusion on product quality must be based on authenticated laboratory findings and established regulatory procedures. In the current absence of any confirmed laboratory report indicating a failure of prescribed quality parameters, it is premature to conclude that the product is adulterated or substandard. Patanjali Foods is closely monitoring the matter and will make further disclosures to the Stock Exchanges as material developments occur or further directions are received from regulatory authorities. The company remains committed to transparency and consumer confidence.
Source: BSE
